Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    April 2017
  1. FISH K, Longnecker R
    EBV germinates lymphoma from the germinal center in a battle with T and NK cells.
    Proc Natl Acad Sci U S A. 2017 Apr 25. pii: 201704102.
    PubMed     Text format    


    March 2017
  2. CHEN J, Zhang Y, Petrus MN, Xiao W, et al
    Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
    Proc Natl Acad Sci U S A. 2017 Mar 29. pii: 201700682.
    PubMed     Text format     Abstract available


    December 2016
  3. LEMONNIER F, Cairns RA, Inoue S, Li WY, et al
    The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development.
    Proc Natl Acad Sci U S A. 2016 Dec 12. pii: 201617929.
    PubMed     Text format     Abstract available


  4. MUKHOPADHYAY C, Triplett A, Bargar T, Heckman C, et al
    Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation.
    Proc Natl Acad Sci U S A. 2016 Dec 5. pii: 201615677.
    PubMed     Text format     Abstract available


    October 2016
  5. CARROLL VA, Lafferty MK, Marchionni L, Bryant JL, et al
    Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201615258.
    PubMed     Text format     Abstract available


  6. RUI L, Drennan AC, Ceribelli M, Zhu F, et al
    Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201610970.
    PubMed     Text format     Abstract available


    May 2016
  7. CORSO J, Pan KT, Walter R, Doebele C, et al
    Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survival.
    Proc Natl Acad Sci U S A. 2016 May 6. pii: 201601053.
    PubMed     Text format     Abstract available


    April 2016
  8. TORCHIA J, Weiskopf K, Levy R
    Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodies.
    Proc Natl Acad Sci U S A. 2016 Apr 25. pii: 201603335.
    PubMed     Text format     Abstract available



  9. Correction for Lee et al., Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice.
    Proc Natl Acad Sci U S A. 2016 Apr 18. pii: 201605284.
    PubMed     Text format    


  10. HODSON DJ, Shaffer AL, Xiao W, Wright GW, et al
    Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2.
    Proc Natl Acad Sci U S A. 2016;113:E2039-46.
    PubMed     Text format     Abstract available


    February 2016
  11. DOOSE G, Hoffmann S, Iaccarino I
    Reply to Hart et al.: MINCR and MYC: More than expression correlation.
    Proc Natl Acad Sci U S A. 2016;113:E498.
    PubMed     Text format    


    January 2016
  12. MAMBETSARIEV N, Lin WW, Stunz LL, Hanson BM, et al
    Nuclear TRAF3 is a negative regulator of CREB in B cells.
    Proc Natl Acad Sci U S A. 2016;113:1032-7.
    PubMed     Text format     Abstract available


  13. JU W, Zhang M, Wilson KM, Petrus MN, et al
    Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma.
    Proc Natl Acad Sci U S A. 2016 Jan 25. pii: 201524668.
    PubMed     Text format     Abstract available


  14. HART JR, Weinberg MS, Morris KV, Roberts TC, et al
    MINCR is not a MYC-induced lncRNA.
    Proc Natl Acad Sci U S A. 2016 Jan 25. pii: 201519903.
    PubMed     Text format    


  15. DEKKER JD, Park D, Shaffer AL 3rd, Kohlhammer H, et al
    Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1.
    Proc Natl Acad Sci U S A. 2016 Jan 19. pii: 201524677.
    PubMed     Text format     Abstract available


  16. WEINSTEIN S, Toker IA, Emmanuel R, Ramishetti S, et al
    Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.
    Proc Natl Acad Sci U S A. 2016;113:E16-22.
    PubMed     Text format     Abstract available


  17. WEISSMANN M, Arvatz G, Horowitz N, Feld S, et al
    Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis.
    Proc Natl Acad Sci U S A. 2016 Jan 4. pii: 201519453.
    PubMed     Text format     Abstract available


    November 2015

  18. Correction to Supporting Information for Dolcetti et al., Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.
    Proc Natl Acad Sci U S A. 2015 Nov 30. pii: 201522501.
    PubMed     Text format    


  19. DOLCETTI R, Giagulli C, He W, Selleri M, et al
    Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.
    Proc Natl Acad Sci U S A. 2015;112:14331-14336.
    PubMed     Text format     Abstract available


  20. VITRE B, Holland AJ, Kulukian A, Shoshani O, et al
    Chronic centrosome amplification without tumorigenesis.
    Proc Natl Acad Sci U S A. 2015;112:E6321-30.
    PubMed     Text format     Abstract available


    October 2015
  21. NEELAPU SS, Sharma P
    Targeting the tumor niche to treat cancer.
    Proc Natl Acad Sci U S A. 2015;112:12907-8.
    PubMed     Text format    


    August 2015
  22. LIN CW, Tsai MH, Li ST, Tsai TI, et al
    A common glycan structure on immunoglobulin G for enhancement of effector functions.
    Proc Natl Acad Sci U S A. 2015;112:10611-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: